SCHEMBL10187475

SCHEMBL10187475

C=CCC(Cc1ccc(-c2ccccc2)cc1)SC(C)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRR Q9GZT4 2/20 0.41
▸ PSAT1 Q9Y617 2/20 0.41
▸ ACACB O00763 1/20 0.41
▸ FFAR1 O14842 1/20 0.41
▸ PPARG P37231 6/20 0.40
▸ PPARA Q07869 5/20 0.40
▸ MME P08473 6/20 0.40
▸ ACE P12821 5/20 0.40
▸ ACE2 Q9BYF1 3/20 0.40
▸ CPA1 P15085 2/20 0.40
▸ ABCC4 O15439 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ MMP2 P08253 1/20 0.39
▸ MMP3 P08254 1/20 0.39
▸ MMP7 P09237 1/20 0.39
▸ MMP9 P14780 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10187481 0.85 FFAR1 (0.44) ACACBFFAR1PPARGPPARAMME
SCHEMBL11834777 0.81 MMP12 (0.48) SRRPSAT1ACACBFFAR1PPARG
SCHEMBL11832270 0.79 SRR (0.46) SRRPSAT1ACACBFFAR1PPARG
SCHEMBL11826818 0.77 ALDH1A1 (0.43) SRRPSAT1ACACBFFAR1PPARG
SCHEMBL11828803 0.77 SRR (0.43) SRRPSAT1ACACBPPARGPPARA
SCHEMBL9230062 0.75 SRR (0.50) SRRPSAT1ACACBFFAR1PPARG
SCHEMBL11827301 0.75 SRR (0.45) SRRPSAT1PPARGPPARAMME
SCHEMBL11821169 0.74 PPARA (0.49) SRRPSAT1PPARGPPARACYP2C19
SCHEMBL1408586 0.72 MME (0.41) SRRPSAT1ACACBMMEACE
SCHEMBL10187476 0.72 SRR (0.46) SRRPSAT1FFAR1PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093287-B2 Inhibitors of matrix metalloproteinases UNIVERSITY OF NOTRE DAME DU LAC (US) 2012-01-10 — — US disclosed
US-20110224275-A1 INHIBITORS OF MATRIX METALLOPROTEINASES NOTRE DAME UNIVERSITY (US) 2011-09-15 — — US disclosed
US-7928127-B2 Inhibitors of matrix metallaproteinases NOTRE DAME UNIVERSITY (US) 2011-04-19 — — US disclosed
US-20090005420-A1 Inhibitors of Matrix Metallaproteinases NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-01-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005420-A1 Inhibitors of Matrix Metallaproteinases MMP9, MMP1, MMP2 SRR 2320/4885PSAT1 1421/4885ACACB 1022/4885
US-20110224275-A1 INHIBITORS OF MATRIX METALLOPROTEINASES MMP9, MMP1, MMP2 SRR 2387/4885PSAT1 2005/4885ACACB 988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback